Kabra Drugs share news, announcements and annual reports
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹15.72.
30 Oct: open ₹15.99, high ₹16.49, low ₹15.67
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 59,920
Kabra Drugs share news and announcements
558 announcements, routine notices left out, newest first. Page 4 of 12.
Mar 2024
Feb 2024
19 Feb · Meeting
17 Feb · Meeting
16 Feb · Submission Of Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
14 Feb · Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 31St December 2023.
14 Feb · Results
5 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Jan 2024
24 Jan · Meeting
24 Jan · Board meeting
24 Jan · Board meeting
18 Jan · Board meeting
Meeting on 23 Jan 2024: increase in authorised capital and preferential issue of shares
Dec 2023
8 Dec · Board meeting
Meeting on 15 Dec 2023
Nov 2023
13 Nov · Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th September 2023.
6 Nov · Board meeting
Meeting on 13 Nov 2023: quarterly results
Oct 2023
14 Oct · Meeting
Sep 2023
9 Sep · Meeting
Aug 2023
28 Aug · Board meeting
Meeting on 2 Sep 202314 Aug · Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June, 2023.
7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
Jun 2023
May 2023
23 May · Board meeting
Meeting on 30 May 2023: audited results12 May · Compliance Certificate Pursuant To Regulation 40(9) And 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2023
Apr 2023
21 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR), Regulations 2015
Feb 2023
15 Feb · Board meeting
6 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Nov 2022
14 Nov · Submission Of Half Yearly Disclosure On Related Party Transactions.
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results